JAAD Quizzes - AAD Learning Portal

false

Search Result for:

JAAD Quizzes

Filters:

Activity

Audience

Credit Type

Featured Courses

Sort By

JAAD 10/26 Part I. Dermatologic Manifestations in Patients with Kidney Disease

Chronic kidney disease brings a wide range of skin findings that are often hard to diagnose and manage. This CME activity covers manifestations of the disease itself, including pruritus, pigmentary changes, and porphyria cutanea tarda, as well as treatment-related dermatoses such as calciphylaxis, dialysis-related amyloidosis, and nephrogenic systemic fibrosis. Build a practical framework for recognizing and managing skin disease across the course of kidney disease and its treatment.

1 CME available

JAAD 10/26 Part II. Dermatologic Manifestations Associated with Treatment of Patients with Kidney Disease

Chronic kidney disease brings a wide range of skin findings that are often hard to diagnose and manage. This CME activity covers manifestations of the disease itself, including pruritus, pigmentary changes, and porphyria cutanea tarda, as well as treatment-related dermatoses such as calciphylaxis, dialysis-related amyloidosis, and nephrogenic systemic fibrosis. Build a practical framework for recognizing and managing skin disease across the course of kidney disease and its treatment.

1 CME available

JAAD 09/26 Wound Care – Part I: A practical approach to local wound care and dressing selection

Wound care is a core dermatologic skill, yet training rarely covers it in depth. This CME activity covers clinical wound assessment and traditional dressing selection (Part I), then tissue-engineered skin substitutes and cellular, acellular, and matrix-like products (Part II). Build a practical framework for matching wound characteristics to the right dressing or biologic therapy.

1 CME available

JAAD 09/26 Wound Care – Part II: Tissue-engineered skin substitutes & other advanced wound therapies

Wound care is a core dermatologic skill, yet training rarely covers it in depth. This CME activity covers clinical wound assessment and traditional dressing selection (Part I), then tissue-engineered skin substitutes and cellular, acellular, and matrix-like products (Part II). Build a practical framework for matching wound characteristics to the right dressing or biologic therapy.

1 CME available

JAAD 08/26 Diagnosis and management of cutaneous infections in immunocompromised hosts part I: cellular immunodeficiency

Immunocompromised patients face distinct infection risks depending on which arm of immunity is impaired. This CME activity covers opportunistic infections in cellular immunodeficiency (mycobacteria, systemic mycoses, protozoa) and in neutropenia and humoral immunodeficiency (ecthyma gangrenosum, opportunistic mycoses, herpesviruses, Neisseria). Sharpen the ability to match cutaneous findings to the underlying immune defect and choose the right diagnostic and treatment approach.

1 CME available

JAAD 08/26 Diagnosis and management of cutaneous infections in immunocompromised hosts part II: neutropenia and humoral immunodeficiency

Immunocompromised patients face distinct infection risks depending on which arm of immunity is impaired. This CME activity covers opportunistic infections in cellular immunodeficiency (mycobacteria, systemic mycoses, protozoa) and in neutropenia and humoral immunodeficiency (ecthyma gangrenosum, opportunistic mycoses, herpesviruses, Neisseria). Sharpen the ability to match cutaneous findings to the underlying immune defect and choose the right diagnostic and treatment approach.

1 CME available

JAAD 07/26 Minimally invasive modalities for keratinocyte carcinomas Part I: Diagnostics

Keratinocyte carcinoma is the most common cancer in the US, yet biopsy and surgery are not always feasible or desired. This CME activity covers noninvasive diagnostic tools, including dermoscopy, confocal microscopy, and optical coherence tomography, then reviews evidence-based treatment alternatives, from topical and intralesional therapies to photodynamic therapy, for patients who are poor surgical candidates. Build a practical toolkit for diagnosing and managing keratinocyte carcinoma when surgery isn't the first choice.

1 CME available

JAAD 07/26 Minimally-invasive modalities for non-melanoma skin cancer Part II: Treatment

Keratinocyte carcinoma is the most common cancer in the US, yet biopsy and surgery are not always feasible or desired. This CME activity covers noninvasive diagnostic tools, including dermoscopy, confocal microscopy, and optical coherence tomography, then reviews evidence-based treatment alternatives, from topical and intralesional therapies to photodynamic therapy, for patients who are poor surgical candidates. Build a practical toolkit for diagnosing and managing keratinocyte carcinoma when surgery isn't the first choice.

1 CME available

JAAD 06/26 Photodynamic Therapy: Overview and Mechanism of Action

Photodynamic therapy (PDT) has expanded well beyond actinic keratoses, with growing evidence across many dermatologic conditions. This CME activity covers PDT's mechanism of action, photosensitizers, and light sources, then reviews its evidence-based clinical applications, from actinic keratoses and basal cell carcinoma to acne, port wine stains, and rosacea. Build a practical, evidence-based framework for incorporating PDT into dermatologic practice.

1 CME available

JAAD 06/26 Photodynamic Therapy: Clinical Applications in Dermatology

Photodynamic therapy (PDT) has expanded well beyond actinic keratoses, with growing evidence across many dermatologic conditions. This CME activity covers PDT's mechanism of action, photosensitizers, and light sources, then reviews its evidence-based clinical applications, from actinic keratoses and basal cell carcinoma to acne, port wine stains, and rosacea. Build a practical, evidence-based framework for incorporating PDT into dermatologic practice.

1 CME available

JAAD CME Supplement – Atopic Dermatitis: Transforming Science and Patient Care

To read the full JAAD Supplements click here.

Atopic dermatitis care has evolved rapidly, from new insight into its pathogenesis to expanding topical, biologic, and JAK inhibitor therapies. This CME supplement spans epidemiology, comorbidities, diagnosis, treatment, and future directions in care. Build a comprehensive, patient-centered framework for diagnosing and managing atopic dermatitis across the lifespan.

10 CME available

JAAD 05/26 Part 1 - The Dermatologic Oral Examination and Biopsy: A Guide for Incorporation into Everyday Practice

The oral mucosa falls within dermatology's purview, yet training in its examination remains limited. This CME activity reviews oral anatomy and provides a step-by-step guide to the dermatologic oral exam and biopsy technique, then introduces the Oral Dermatoses Map, organizing key conditions by anatomical site of involvement. Strengthen the ability to examine, diagnose, and manage disorders of the oral cavity in everyday practice.

1 CME available

JAAD 05/26 Part 2 - The Dermatologic Oral Examination: Navigating the Oral Dermatoses Map

The oral mucosa falls within dermatology's purview, yet training in its examination remains limited. This CME activity reviews oral anatomy and provides a step-by-step guide to the dermatologic oral exam and biopsy technique, then introduces the Oral Dermatoses Map, organizing key conditions by anatomical site of involvement. Strengthen the ability to examine, diagnose, and manage disorders of the oral cavity in everyday practice.

1 CME available

JAAD 04/26 Frontal Fibrosing Alopecia (FFA) Part I - Diagnosis and Clinical Presentation

Frontal fibrosing alopecia is on the rise, and its slow, scarring progression makes early recognition critical. This CME activity covers the demographics, clinical subtypes, and trichoscopy findings that define FFA, then digs into its proposed etiopathogenesis and the treatment strategies used to stabilize disease progression. Sharpen your ability to recognize and manage this increasingly common cause of scarring hair loss.

1 CME available

JAAD 04/26 Frontal Fibrosing Alopecia Part II: Etiopathogenesis and Management

Frontal fibrosing alopecia is on the rise, and its slow, scarring progression makes early recognition critical. This CME activity covers the demographics, clinical subtypes, and trichoscopy findings that define FFA, then digs into its proposed etiopathogenesis and the treatment strategies used to stabilize disease progression. Sharpen your ability to recognize and manage this increasingly common cause of scarring hair loss.

1 CME available

JAAD 03/26 Disability and the Dermatology Patient - Part 1: Improving Access to Dermatologic Care

Patients with disabilities make up a significant share of dermatology practices, yet many clinicians receive little training on how to best serve them. This CME activity covers how to make dermatologic care more accessible for patients with cognitive, motor, visual, and hearing disabilities, then turns to dermatologic conditions that can themselves cause disability, including how to identify, document, and support patients through the disability process. Learn practical strategies to deliver more accessible, patient-centered care.

1 CME available

JAAD 03/26 Disability and the Dermatology Patient – Part 2: Supporting Patients with Disabilities

Patients with disabilities make up a significant share of dermatology practices, yet many clinicians receive little training on how to best serve them. This CME activity covers how to make dermatologic care more accessible for patients with cognitive, motor, visual, and hearing disabilities, then turns to dermatologic conditions that can themselves cause disability, including how to identify, document, and support patients through the disability process. Learn practical strategies to deliver more accessible, patient-centered care.

1 CME available

JAAD 02/26 Acral Lentiginous Melanoma. Part I. Epidemiology, Etiology, Molecular Profile, Clinical Presentation, and Diagnosis

Acral lentiginous melanoma is rare, easy to overlook, and disproportionately deadly for patients of color. This CME activity explores the epidemiology, molecular landscape, and diagnostic clues that set ALM apart from other melanomas, then moves into staging, surgical management, and the systemic therapies shaping outcomes in advanced disease. Build the clinical instincts to catch ALM earlier and manage it more effectively.

1 CME available

JAAD 02/26 Acral Lentiginous Melanoma. Part II. Staging, Surgical Management, The Role of Systemic Therapy, Shortcomings and Future Directions

Acral lentiginous melanoma is rare, easy to overlook, and disproportionately deadly for patients of color. This CME activity explores the epidemiology, molecular landscape, and diagnostic clues that set ALM apart from other melanomas, then moves into staging, surgical management, and the systemic therapies shaping outcomes in advanced disease. Build the clinical instincts to catch ALM earlier and manage it more effectively.

1 CME available

JAAD 01/26 Augmented Intelligence and Dermatology - Part I: Core Concept and Applications

AI is transforming dermatology, but are you ready to use it wisely? This CME activity breaks down the essentials, from how AI models are built to where bias, ethics, and regulation come into play. Learn to speak the language of AI and critically evaluate the tools shaping the future of skin care.

1 CME available

Course 1 to 20 of 76

Image For Banner

Image For Banner

Image For Banner

Image For Banner

Image For Banner

Image For Banner